Characteristic | Total (n = 104) | Patients with bowel damage (n = 47) | Patients without bowel damage (n = 57) | P value |
---|---|---|---|---|
Age at diagnosis, year, median (IQR) | 28.0 (11.8) | 32.0 (13.0) | 24.0 (9.0) | 0.047 |
Gender, (%) | 0.067 | |||
Male | 85 (81.7) | 42 (89.4) | 43 (75.4) | |
Female | 19 (18.3) | 5 (8.6) | 14 (24.6) | |
Symptom duration before diagnosis, month, median (IQR) | 15.9 (40.1) | 36.0 (66.9) | 11.1 (22.2) | <0.001 |
Location, (%) | 0.431 | |||
L1 (ileal) | 20 (19.2) | 12 (25.5) | 8 (14.0) | |
L2 (colonic) | 4 (3.8) | 1 (2.1) | 3 (5.3) | |
L3 (ileocolonic) | 45 (43.3) | 19 (40.4) | 26 (45.6) | |
L4 (only upper GI) | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
L1–L4 | 11 (10.6) | 5 (10.6) | 6 (10.5) | |
L2–L4 | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
L3–L4 | 24 (23.1) | 10 (21.3) | 14 (24.6) | |
Behavior at diagnosis, (%) | 0.002 | |||
B1 (non-stricturing, non-penetrating) | 23 (22.1) | 0 (0.0) | 23 (22.1) | |
B2 (stricturing) | 11 (10.6) | 11 (10.6) | 0 (0.0) | |
B3 (penetrating) | 18 (17.3) | 18 (17.3) | 0 (0.0) | |
B1-P | 34 (32.7) | 0 (0.0) | 34 (32.7) | |
B2-P | 8 (7.7) | 8 (7.7) | 0 (0.0) | |
B3-P | 10 (9.6) | 10 (9.6) | 0 (0.0) | |
BMI, median (IQR) | 19.7 (3.7) | 19.2 (3.9) | 20.3 (3.6) | 0.206 |
CRP, median (IQR) | 1.6 (3.6) | 1.6 (3.6) | 1.6 (3.6) | 0.268 |
ESR, median (IQR) | 38.0 (50.5) | 32.0 (49.0) | 30.0 (58.0) | 0.981 |
Hct, median (IQR) | 39.5 (6.9) | 39.1 (7.0) | 39.9 (6.9) | 0.800 |
CDAI, median (IQR) | 180.4 (36.6) | 187.4 (40.2) | 177.6 (36.3) | 0.975 |